Skip to content
TTM Q4 '26TTM Q3 '26TTM Q2 '26TTM Q1 '26TTM Q4 '25
$1.4B+3.2%$1.4B+1.6%$1.39B+1.2%$1.38B-0.8%$1.36B-3.9%
$1.09B+8.4%$1.08B+8.0%$1.07B+7.0%$1.04B+2.6%$1B-4.6%
$319.47M-11.2%$315.29M-15.7%$321.45M-14.3%$336.16M-9.9%$359.89M-2.0%
22.7%-3.7pp22.5%-4.6pp23.1%-4.2pp24.4%-2.5pp26.4%+0.5pp
$11.2M-61.4%$15.65M-46.6%$20.1M-32.2%$24.55M-18.1%$29M-4.3%
$235M-2.8%$250.46M+4.4%$252.87M+9.0%$252.5M+9.0%$241.78M+3.6%
$84.47M-28.5%$64.83M-51.6%$68.58M-52.0%$83.66M-40.9%$118.11M-11.7%
6%-2.7pp4.6%-5.1pp4.9%-5.5pp6.1%-4.1pp8.7%-0.8pp
$13.98M+127%$14.67M+310%$12.49M+213%$9.56M+88.0%$6.16M-7.6%
$6.96M+1,017%$7.05M$4.65M-$202K$623K
$77.46M-31.2%$57.21M-55.7%$60.74M-55.6%$73.9M-46.8%$112.57M-12.9%
$23.33M-15.2%$17.21M-44.2%$16.31M-49.8%$22.55M-29.2%$27.52M-7.1%
$54.13M-36.4%$40M-59.3%$44.44M-57.4%$51.35M-52.0%$85.05M-14.6%
3.9%-2.4pp2.9%-4.3pp3.2%-4.4pp3.7%-4.0pp6.2%-0.8pp
$2.52-35.4%$1.87-58.3%$2.06-56.6%$2.36-51.5%$3.90-13.5%
$134.47M-17.4%$116.1M-33.7%$118.47M-35.4%$130.73M-28.5%$162.72M-7.2%
9.6%-2.4pp8.3%-4.4pp8.5%-4.8pp9.5%-3.7pp12%-0.4pp
$84.47M-28.5%$64.83M-51.6%$68.58M-52.0%$83.66M-40.9%$118.11M-11.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Apogee Enterprises's revenue?
Apogee Enterprises (APOG) generated $1.4B in revenue over the trailing twelve months, up 3.2% year over year.
Is Apogee Enterprises profitable?
Apogee Enterprises reported $54.1M in net income over the trailing twelve months, a 3.9% net margin.
What are Apogee Enterprises's profit margins?
Gross margin is 22.7% and operating margin is 6.0%, with a 3.9% net margin.
What is Apogee Enterprises's earnings per share?
Apogee Enterprises's diluted EPS over the trailing twelve months is $2.52.
Where does Apogee Enterprises's income statement data come from?
Every line is extracted from Apogee Enterprises's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.